Pfizer cuts Haleon stake in discounted share sale
Pfizer nets $3.36 billion in share saleHaleon completes £500 million share repurchaseSanofi plans to divest consumer healthcare unitStrong demand from US investors allowed pharmaceutical giant Pfizer (PFE:NYSE) to sell an upscaled 640 million shares in consumer healthcare group Haleon (HLN) at 380p, representing a 3.3% discount to the prior close.Investors focused on the positive implications of